Flu Vaccines: Egg-Based Manufacturing Questioned At Hill Hearing

Rep. DeGette criticizes 'market forces' that are delaying move to cell-based and recombinant technology in sharp questioning of FDA’s Karen Midthun; HHS considering delay in finalizing vaccine composition.